EcoR1 Capital as of June 30, 2016
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 32 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ironwood Pharmaceuticals (IRWD) | 12.5 | $32M | 2.4M | 13.07 | |
Galapagos Nv- (GLPG) | 9.6 | $24M | 439k | 55.47 | |
Retrophin | 8.6 | $22M | 1.2M | 17.81 | |
Cytokinetics (CYTK) | 8.0 | $20M | 2.1M | 9.49 | |
Assembly Biosciences | 6.4 | $16M | 2.9M | 5.55 | |
Fibrogen (FGEN) | 5.1 | $13M | 789k | 16.41 | |
Acceleron Pharma | 5.0 | $13M | 371k | 33.98 | |
Gilead Sciences Inc option | 4.9 | $13M | 150k | 83.42 | |
Allergan Plc call | 4.6 | $12M | 50k | 231.10 | |
Intra Cellular Therapies (ITCI) | 3.8 | $9.5M | 245k | 38.82 | |
Dermira | 3.1 | $8.0M | 272k | 29.25 | |
Epizyme | 3.0 | $7.7M | 755k | 10.24 | |
Ironwood Pharmaceuticals Inc cl a | 3.0 | $7.6M | 582k | 13.08 | |
Kura Oncology (KURA) | 2.6 | $6.7M | 2.5M | 2.71 | |
Intellia Therapeutics (NTLA) | 2.6 | $6.6M | 311k | 21.35 | |
Achaogen | 2.4 | $6.0M | 1.6M | 3.79 | |
Beigene (BGNE) | 2.1 | $5.2M | 175k | 29.80 | |
Kindred Biosciences | 2.0 | $5.1M | 1.4M | 3.54 | |
Nabriva Therapeutics | 1.7 | $4.2M | 563k | 7.50 | |
Syndax Pharmaceuticals (SNDX) | 1.4 | $3.5M | 357k | 9.85 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.3 | $3.3M | 282k | 11.85 | |
Xencor (XNCR) | 1.3 | $3.2M | 168k | 18.99 | |
Enanta Pharmaceuticals (ENTA) | 1.2 | $3.0M | 137k | 22.05 | |
Editas Medicine (EDIT) | 0.8 | $2.1M | 86k | 24.39 | |
Array Biopharma | 0.7 | $1.9M | 520k | 3.56 | |
Forward Pharma A/s | 0.6 | $1.5M | 84k | 18.17 | |
Immunogen Inc Cmn Stk cmn | 0.4 | $923k | 300k | 3.08 | |
Akari Therapeutics | 0.3 | $856k | 64k | 13.49 | |
Tesaro | 0.3 | $773k | 9.2k | 84.02 | |
Advaxis | 0.3 | $751k | 93k | 8.09 | |
Targacept Inc Conv Dtd convertible | 0.3 | $669k | 669k | 1.00 | |
Eiger Biopharmaceuticals | 0.1 | $281k | 14k | 19.80 |